A landmark in drug discovery based on complex natural product synthesis

被引：29

作者：

Kawano, Satoshi ^{[1
]}

Ito, Ken ^{[1
]}

Yahata, Kenzo ^{[2
]}

Kira, Kazunobu ^{[1
]}

Abe, Takanori ^{[1
]}

Akagi, Tsuyoshi ^{[1
]}

Asano, Makoto ^{[1
]}

Iso, Kentaro ^{[1
]}

Sato, Yuki ^{[1
]}

Matsuura, Fumiyoshi ^{[3
]}

Ohashi, Isao ^{[1
]}

Matsumoto, Yasunobu ^{[1
]}

Isomura, Minetaka ^{[1
]}

Sasaki, Takeo ^{[1
]}

Fukuyama, Takashi ^{[1
]}

Miyashita, Yusuke ^{[4
]}

Kaburagi, Yosuke ^{[1
]}

Yokoi, Akira ^{[1
]}

Asano, Osamu ^{[1
]}

Owa, Takashi ^{[5
]}

Kishi, Yoshito ^{[2
]}

机构：

[1] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan

[2] Harvard Univ, Cambridge, MA 02138 USA

[3] Eisai & Co Ltd, Bunkyo Ku, Tokyo, Japan

[4] Eisai & Co Ltd, Kamisu, Ibaraki, Japan

[5] Eisai Inc, Woodcliff Lake, NJ USA

来源：

SCIENTIFIC REPORTS | 2019年 / 9卷 / 1期

关键词：

ANTITUMOR POLYETHER MACROLIDES; ANTINEOPLASTIC AGENTS; HALICHONDRIN-B; BREAST-CANCER; TUBULIN; ANTIBODY; MICROTUBULES; CETUXIMAB; DISEASE; BINDING;

D O I：

10.1038/s41598-019-45001-9

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Despite their outstanding antitumour activity in mice, the limited supply from the natural sources has prevented drug discovery/development based on intact halichondrins. We achieved a total synthesis of C52-halichondrin-B amine (E7130) on a >10 g scale with >99.8% purity under GMP conditions. Interestingly, E7130 not only is a novel microtubule dynamics inhibitor but can also increase intratumoural CD31-positive endothelial cells and reduce alpha-SMA-positive cancer-associated fibroblasts at pharmacologically relevant compound concentrations. According to these unique effects, E7130 significantly augment the effect of antitumour treatments in mouse models and is currently in a clinical trial. Overall, our work demonstrates that a total synthesis can address the issue of limited material supply in drug discovery/development even for the cases of complex natural products.

引用

页数：9

共 50 条

[21] Lasker rewards natural product drug discovery
不详
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (10) : 721 - 721
[22] A GLIMPSE INTO NATURAL PRODUCT DRUG DISCOVERY AT EISAI
Postema, Maarten H. D.
ANTICANCER RESEARCH, 2014, 34 (10) : 6118 - 6119
[23] The role of natural product chemistry in drug discovery
Butler, MS
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (12): : 2141 - 2153
[24] Mixed fermentation for natural product drug discovery
Robin K. Pettit
Applied Microbiology and Biotechnology, 2009, 83 : 19 - 25
[25] Guiding principles for natural product drug discovery
Camp, David
Davis, Rohan A.
Evans-Illidge, Elizabeth A.
Quinn, Ronald J.
FUTURE MEDICINAL CHEMISTRY, 2012, 4 (09) : 1067 - 1084
[26] Metabolomics at the Service of Natural Product Drug Discovery
Roullier, Catherine
MARINE DRUGS, 2020, 18 (01)
[27] Bioassay development in natural product drug discovery
Vuorela, P.
PLANTA MEDICA, 2006, 72 (11) : 962 - 962
[28] Discovery, Synthesis and Antimalarial Evaluation of Natural Product-based Polyamines
Choomuenwai, V
Schwartz, B. D.
Beattie, K. D.
Andrews, K. T.
Khokhar, S.
Davis, R. A.
PLANTA MEDICA, 2013, 79 (10) : 825 - 825
[29] Endophytes: exploiting biodiversity for the improvement of natural product-based drug discovery
Staniek, Agata
Woerdenbag, Herman J.
Kayser, Oliver
JOURNAL OF PLANT INTERACTIONS, 2008, 3 (02) : 75 - 93
[30] Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?
Bisson, Jonathan
McAlpine, James B.
Friesen, J. Brent
Chen, Shao-Nong
Graham, James
Pauli, Guido F.
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 1671 - 1690

← 1 2 3 4 5 →